Review of consensus interferon in the treatment of chronic hepatitis C

Código QR

Review of consensus interferon in the treatment of chronic hepatitis C

Th Witth&ouml;ft1University Hospital Schleswig Holstein Campus L&uuml;beck, Dept of Medicine I, Division of Gastroenterology, L&uuml;beck, Germany. 1Current address is the correspondence addressAbstract: Consensus interferon (CIFN) is an artificially engineered interferon tha...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autor principal:	Th Witth&ouml;ft
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2008
Materias:	Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/5cd098d029a148ca966c30ef6b77c958
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Management of chronic hepatitis C treatment failures: role of consensus interferon
por: Stevan A Gonzalez, et al.
Publicado: (2009)

Treatment of experienced and na&iuml;ve patients with hepatitis C: focus on telaprevir
por: D&#39;Ambrosio R, et al.
Publicado: (2012)

SOFOSBUVIR-VELPATASVIR THERAPY IN THE TREATMENT OF CHRONIC HEPATITIS C GENOTYPE 3
por: Arif Qayyum Khan, et al.
Publicado: (2021)

Effects of interferon-alpha treatment on the incidence of hyperglycemia in chronic hepatitis C patients: a systematic review and meta-analysis.
por: Wei Zhang, et al.
Publicado: (2012)

Review of interferon beta-1b in the treatment of early and relapsing multiple sclerosis
por: Damiano Paolicelli, et al.
Publicado: (2009)

New developments in the management of hepatitis C virus infection: focus on boceprevir
por: Berenguer M, et al.
Publicado: (2012)

Treatment of neuroblastoma and rhabdomyosarcoma using RGD-modified liposomal formulations of patupilone (EPO906)
por: Scherzinger-Laude K, et al.
Publicado: (2013)

Enhanced dermal delivery of diflucortolone valerate using lecithin/chitosan nanoparticles: in-vitro and in-vivo evaluations
por: &Ouml;zcan İ, et al.
Publicado: (2013)

EFFICACY OF FIRST AVAILABLE DIRECT-ACTING ANTIVIRAL AGENT IN TREATMENT OF CHRONIC HEPATITIS C; RESULTS FROM A SINGLE CENTRE IN PAKISTAN
por: Arif Qayyum Khan, et al.
Publicado: (2020)

Nanomedicines in the treatment of hepatitis C virus infection in Asian patients: optimizing use of peginterferon alfa
por: Liu CH, et al.
Publicado: (2014)

Suppression of Interferon-α Treatment Response by Host Negative Factors in Hepatitis B Virus Infection
por: Jiayi Wang, et al.
Publicado: (2021)

Role of TGF-β1 Codon 10 Polymorphism in Chronic Hepatitis C Patients
por: P Azimzadeh, et al.
Publicado: (2011)

A new approach to the treatment of recurrent aphthous stomatitis with bioadhesive gels containing cyclosporine A solid lipid nanoparticles: in vivo/in vitro examinations
por: Karavana SY, et al.
Publicado: (2012)

Early stage and long term treatment of multiple sclerosis with interferon-&beta;
por: Angela Applebee, et al.
Publicado: (2009)

PEGylated interferon beta-1a in the treatment of multiple sclerosis – an update
por: Reuss R
Publicado: (2013)

Long-term pegylated interferon-&alpha; and its potential in the treatment of melanoma
por: Reinhard Dummer, et al.
Publicado: (2009)

EFFICACY OF FIRST AVAILABLE DIRECT-ACTING ANTIVIRAL AGENT IN TREATMENT OF CHRONIC HEPATITIS C; RESULTS FROM A SINGLE CENTRE IN PAKISTAN
por: Arif Qayyum Khan, et al.
Publicado: (2020)

The Chinese consensus for surgical treatment of traumatic rib fractures 2021 (C-STTRF 2021)
por: Ling-Wen Kong, et al.
Publicado: (2021)

FREQUENCY OF HEPATOCELLULAR CARCINOMA AND ASSOCIATED SOCIODEMOGRAPHIC FACTORS IN TREATED PATIENTS OF CHRONIC HEPATITIS C
por: Rabia Tariq, et al.
Publicado: (2021)

DIAGNOSTIC ACCURACY OF SPLENIC ARTERY PULSATILITY INDEX IN PREDICTING FIBROSIS ASSOCIATED WITH CHRONIC HEPATITIS C
por: Hidayat Ullah, et al.
Publicado: (2018)

The role of surface charge in cellular uptake and cytotoxicity of medical nanoparticles
por: Fr&ouml;hlich E
Publicado: (2012)

Exercise for Neuropathic Pain: A Systematic Review and Expert Consensus
por: Yong-Hui Zhang, et al.
Publicado: (2021)

Efficacy and safety of pegylated interferon plus ribavirin therapy for chronic hepatitis C genotype 6: a meta-analysis.
por: Xiwei Wang, et al.
Publicado: (2014)

Interferon-free combination therapies for the treatment of hepatitis C: current insights
por: Holmes JA, et al.
Publicado: (2015)

Blood Levels of Glutamine and Nitrotyrosine in Patients with Chronic Viral Hepatitis
por: Murad H, et al.
Publicado: (2021)

Efficacy of Ombitasvir/Paritaprevir/Ritonavir plus Ribavirin in Treatment of Chronic Hepatitis C Patients with End Stage Renal Disease on Regular Hemodialysis
por: Naglaa El-Gendy, et al.
Publicado: (2020)

Ustekinumab in the therapy of chronic plaque psoriasis
por: Jenna L O&rsquo;Neill, et al.
Publicado: (2009)

Chronic hepatitis C: future treatment
por: Wendt A, et al.
Publicado: (2014)

Potential role of ustekinumab in the treatment of chronic plaque psoriasis
por: Santo Raffaele Mercuri, et al.
Publicado: (2010)

Dasatinib in the treatment of imatinib refractory chronic myeloid leukemia
por: Radhakrishnan Ramchandren, et al.
Publicado: (2009)

Relationship between occult hepatitis B virus infection and chronic kidney disease in a Chinese population-based cohort
por: Xiang-Lei Kong, et al.
Publicado: (2016)

Risk factors for the development of depression in patients with hepatitis C taking interferon-&alpha;
por: Smith KJ, et al.
Publicado: (2011)

ASSOCIATIONS OF INTERFERON GENE POLYMORPHISMS OAS-1, OAS-3, PKR WITH CHRONIC VIRAL HEPATITIS C
por: V. A. Bychkov, et al.
Publicado: (2014)

&nbsp;&alpha;-Cyclodextrin dimer complexes of dopamine and levodopa derivatives to assess drug delivery to the central nervous system: ADME and molecular docking studies
por: Shityakov S, et al.
Publicado: (2012)

Detection of nanolevel drug metabolites in an organotypic culture of primary human hepatocytes and porcine hepatocytes with special reference to a two-compartment model
por: Acikg&ouml;z A, et al.
Publicado: (2012)

Efficacy and safety of anakinra for the treatment of rheumatoid arthritis: an update of the Oregon Drug&nbsp; Effectiveness Review Project
por: Kylie Thaler, et al.
Publicado: (2009)

Gd2O3 nanoparticles in hematopoietic cells for MRI contrast enhancement
por: Hedlund A, et al.
Publicado: (2011)

Treatment of hepatitis C in children: a systematic review.
por: Jia Hu, et al.
Publicado: (2010)

Tumor targeting using liposomal antineoplastic drugs
por: J&ouml;rg Huwyler, et al.
Publicado: (2008)

Mass prevention and treatment: Fundamental strategy for chronic disease control and prevention
por: Da-Yi Hu
Publicado: (2016)